The Journal of Organic Chemistry
Article
(dt, J = 7.6, 1.5 Hz, 1 H), 7.54−7.50 (m, 2 H), 7.44−7.32 (m, 5 H),
7.30−7.27 (m, 2 H), 7.17 (dt, J = 8.2, 2.2 Hz, 1 H), 7.13−7.11 (m, 1 H)
ppm. 13C{1H} NMR (125 MHz, CDCl3): δ = 194.6, 163.6, 161.6,
152.4, 149.4, 140.9, 139.8, 139.7, 138.7, 137.7, 129.9, 129.8, 127.8,
127.0, 126.0, 125.9, 124.0, 123.9, 123.5, 122.2, 121.6, 120.5, 120.5,
120.4, 119.7, 119.6, 116.1, 116.0, 110.3 ppm. HRMS (ESI): calcd for
C24H16FN2O [M + H]+ 367.1241; found 367.1243.
(2-Fluorophenyl)(9-(pyridin-2-yl)-9H-carbazol-1-yl)methanone
(3h). Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 85:15); yellow solid (33% using
GP-1), mp 210−212 °C. 1H NMR (500 MHz, CDCl3): δ = 8.31 (d, J =
7.0 Hz, 2 H), 8.15 (d, J = 7.7 Hz, 1 H), 7.79 (dt, J = 7.9, 1.9 Hz, 1 H),
7.57−7.54 (m, 2 H), 7.44−7.33 (m, 6 H), 7.16−7.14 (m, 1 H), 7.09 (t, J
= 7.6 Hz, 1 H), 7.03−6.99 (m, 1 H) ppm. 13C NMR{1H} (125 MHz,
CDCl3): δ = 192.2, 162.0, 152.8, 149.5, 141.3, 138.8, 137.6, 133.9,
133.8, 132.0, 128.4, 126.9, 126.3, 125.3, 124.0, 123.9, 122.2, 121.6,
120.5, 120.4, 120.1, 116.8, 116.6, 110.7 ppm. HRMS (ESI): calcd for
C24H16FN2O [M + H]+ 367.1241; found 367.1243.
4-(9-(Pyridin-2-yl)-9H-carbazole-1-carbonyl)benzonitrile (3i).
Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 80:20); white solid (77% using
GP-1), mp 242−244 °C. 1H NMR (500 MHz, CDCl3): δ = 8.33 (d, J =
7.5, Hz, 1 H), 8.17 (d, J = 7.7 Hz, 1 H), 8.09 (d, J = 4.9 Hz, 1 H), 7.87
(dd, J = 5.3, 3.1 Hz, 1 H), 7.79−7.75 (m, 2 H), 7.67 (d, J = 8.3 Hz, 2 H),
7.61 (d, J = 8.3 Hz, 2 H), 7.51 (t, J = 8.1 Hz, 2 H), 7.45−7.33 (m, 2 H),
7.11 (dd, J = 7.3, 5.0 Hz, 1 H) ppm. 13C{1H} NMR (100 MHz,
CDCl3): δ = 194.2, 168.0, 152.3, 149.3, 140.8, 140.7, 138.9, 137.6,
134.4, 132.8, 132.1, 130.1, 127.8, 127.2, 126.2, 123.9, 123.7, 123.2,
122.2, 121.8, 120.6, 120.3, 118.2, 115.7, 110.3 ppm. HRMS (ESI): calcd
for C25H15N3ONa [M + Na]+ 396.1107; found 396.1115.
Hz, 1 H), 7.77−7.74 (m, 1 H), 7.58 (d, J = 8.3 Hz, 1 H), 7.53 (d, J = 7.3
Hz, 1 H), 7.42−7.37 (m, 3 H), 7.35−7.31 (m, 3 H), 7.14−7.12 (m, 1
H), 6.89−6.84 (m, 2 H), 3.61 (s, 3 H) ppm. 13C{1H} NMR (100 MHz,
CDCl3): δ = 194.4, 158.4, 153.0, 149.4, 141.5, 138.5, 137.7, 134.5,
134.4, 133.0, 131.7, 129.0, 128.2, 126.8, 126.3, 126.1, 123.9, 123.6,
121.8, 121.4, 120.3, 120.2, 111.8, 110.8, 55.7 ppm. HRMS (ESI): calcd
for C25H19N2O2 [M + H]+ 379.1441; found 379.1445.
(9-(Pyridin-2-yl)-9H-carbazol-1-yl)(m-tolyl)methanone (3n).
Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 85:15); white solid (70% using
GP-1), mp 200−204 °C. 1H NMR (400 MHz, CDCl3): δ = 8.29 (dd, J
= 7.7, 1.1 Hz, 1 H), 8.17 (d, J = 7.6 Hz, 1 H), 8.13 (dd, J = 4.9, 1.2 Hz, 1
H), 7.73 (dt, J = 7.8, 1.9 Hz, 1 H), 7.54 (dd, J = 7.4, 1.1 Hz, 1 H), 7.50
(d, J = 8.3 Hz, 1 H), 7.43−7.27 (m, 7 H), 7.19 (t, J = 7.5 Hz, 1 H), 7.10
(ddd, J = 7.4, 4.9, 0.8 Hz, 1 H), 2.31 (s, 3 H) ppm. 13C{1H} NMR (100
MHz, CDCl3): δ = 196.2, 152.4, 149.4, 141.0, 138.6, 138.0, 137.9,
137.7, 133.4, 130.1, 128.1, 128.0, 127.4, 126.8, 125.9, 124.6, 124.0,
123.1, 121.9, 121.2, 120.6, 120.5, 120.3, 110.3, 21.4 ppm. HRMS (ESI):
calcd for C25H19N2O [M + H]+ 363.1492; found 363.1497.
(9-(Pyridin-2-yl)-9H-carbazol-1-yl)(o-tolyl)methanone (3o). Prod-
uct was purified using column chromatography on silica gel (eluent:
hexane/ethyl acetate 95:5 to 85:15); white solid (66% using GP-1), mp
190−194 °C. 1H NMR (400 MHz, CDCl3): δ = 8.30−8.27 (m, 2 H),
8.16 (d, J = 7.7 Hz, 1 H), 7.84 (dt, J = 7.8, 1.7 Hz, 1 H), 7.52−7.40 (m, 4
H), 7.39−7.31 (m, 4 H), 7.20−7.12 (m, 3 H), 2.34 (s, 3 H) ppm.
13C{1H} NMR (100 MHz, CDCl3): δ = 197.2, 152.8, 149.3, 141.4,
138.7, 138.6, 138.0, 137.7, 131.4, 131.2, 129.1, 127.9, 127.6, 126.8,
126.2, 125.9, 125.4, 123.8, 123.7, 122.1, 121.4, 120.4, 120.3, 110.4, 21.0
ppm. HRMS (ESI): calcd for C25H19N2O [M + H]+ 363.1492; found
363.1495.
3-(9-(Pyridin-2-yl)-9H-carbazole-1-carbonyl)benzonitrile (3j).
Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 80:20); white solid (75% using
GP-1), mp 228−232 °C. 1H NMR (500 MHz, CDCl3): δ = 8.33 (dd, J
= 7.7, 0.9 Hz, 1 H), 8.18 (d, J = 7.7 Hz, 1 H), 8.10 (dd, J = 4.8, 1.2 Hz, 1
H), 7.86 (s, 1 H), 7.79−7.73 (m, 3 H), 7.51 (d, J = 7.6 Hz, 2 H), 7.45−
7.32 (m, 5 H), 7.16−7.13 (m, 1 H) ppm. 13C{1H} NMR (100 MHz,
CDCl3): δ = 193.7, 152.4, 149.3, 140.8, 138.9, 138.6, 137.6, 135.4,
134.4, 133.8, 133.1, 129.2, 127.7, 127.2, 126.2, 123.9, 123.7, 123.1,
122.3, 121.8, 120.6, 120.4, 118.0, 112.8, 110.3 ppm. HRMS (ESI): calcd
for C25H16N3O [M + H]+ 374.1288; found 374.1287.
(3,5-Dimethylphenyl)(9-(pyridin-2-yl)-9H-carbazol-1-yl)-
methanone (3p). Product was purified using column chromatography
on silica gel (eluent: hexane/ethyl acetate 95:5 to 85:15); white solid
(43% using GP-1), mp 206−208 °C. 1H NMR (400 MHz, CDCl3): δ =
8.29 (dd, J = 6.7, 1.2 Hz, 1 H), 8.18−8.14 (m, 2 H), 7.75 (dt, J = 7.7, 1.8
Hz, 1 H), 7.53−7.48 (m, 2 H), 7.43−7.33 (m, 4 H), 7.21 (s, 2 H),
7.11−7.09 (m, 2 H), 2.23 (s, 6 H) ppm. 13C{1H} NMR (100 MHz,
CDCl3): δ = 196.5, 152.4, 149.4, 141.0, 138.6, 137.9, 137.8, 137.7,
134.3, 128.1, 127.6, 126.8, 125.9, 124.7, 124.0, 123.1, 121.9, 121.3,
120.6, 120.4, 120.2, 110.2, 21.2 ppm. HRMS (ESI): calcd for
C26H21N2O [M + H]+ 377.1648; found 377.1649.
(4-Chlorophenyl)(3,6-dichloro-9-(pyridin-2-yl)-9H-carbazol-1-yl)-
methanone (10b). Product was purified using column chromatog-
raphy on silica gel (eluent: hexane/ethyl acetate 95:5 to 85:15); white
solid (83% using GP-1), mp 222−224 °C. 1H NMR (500 MHz,
CDCl3): δ = 8.18 (d, J = 1.7 Hz, 1 H), 8.07−8.06 (m, 2 H), 7.80−7.77
(m, 1 H), 7.56 (d, J = 8.4 Hz, 2 H), 7.46 (d, J = 2.2 Hz, 1 H), 7.40−7.39
(m, 2 H), 7.33 (d, J = 8.6 Hz, 3 H), 7.13−7.11 (m, 1 H) ppm. 13C{1H}
NMR (125 MHz, CDCl3): δ = 193.3, 151.5, 149.4, 139.6, 139.0, 136.5,
135.2, 131.3, 129.5, 128.8, 127.8, 127.7, 127.4, 126.3, 126.2, 125.3,
124.2, 122.8, 122.7, 120.4, 120.3, 111.6 ppm. HRMS (ESI): calcd for
C24H14Cl3N2O [M + H]+ 451.0166; found 451.0162.
Methyl 4-(9-(pyridin-2-yl)-9H-carbazole-1-carbonyl)benzoate
(3k). Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 75:25); white solid (79% using
1
GP-1 and 69% using GP-2), mp 160−162 °C. H NMR (500 MHz,
CDCl3): δ = 8.31 (d, J = 7.6 Hz, 1 H), 8.17 (d, J = 7.7 Hz, 1 H), 8.09 (d,
J = 3.6 Hz, 1 H), 7.97 (d, J = 8.3 Hz, 2 H), 7.87−7.86 (m, 1 H), 7.76−
7.73 (m, 2 H), 7.64 (d, J = 8.2 Hz, 2 H), 7.53−7.49 (m, 2 H), 7.43−7.31
(m, 2 H), 7.09−7.07 (m, 1 H), 3.94 (s, 3 H) ppm. 13C{1H} NMR (125
MHz, CDCl3): δ = 195.2, 168.0, 166.5, 152.4, 149.3, 141.0, 140.9,
138.8, 137.8, 134.4, 133.4, 132.8, 129.7, 129.4, 127.9, 127.0, 126.1,
124.0, 123.7, 123.6, 122.2, 121.6, 120.5, 120.4, 110.3, 52.5 ppm. HRMS
(ESI): calcd for C26H18N2O3Na [M + Na]+ 429.1210; found 429.1213.
1-(4-(9-(Pyridin-2-yl)-9H-carbazole-1-carbonyl)phenyl)ethanone
(3l). Product was purified using column chromatography on silica gel
(eluent: hexane/ethyl acetate 95:5 to 75:25); white solid (94% using
GP-1), mp 168−172 °C. 1H NMR (400 MHz, CDCl3): δ = 8.31 (d, J =
7.6 Hz, 1 H), 8.16 (d, J = 7.6 Hz, 1 H), 8.07 (d, J = 3.7 Hz, 1 H), 7.88 (d,
J = 8.2 Hz, 2 H), 7.74 (dt, J = 7.7, 1.6 Hz, 1 H), 7.68 (d, J = 8.2 Hz, 2 H),
7.51 (d, J = 7.8 Hz, 2 H), 7.44−7.34 (m, 4 H), 7.08 (dd, J = 7.1, 5.1 Hz, 1
H), 2.61 (s, 3 H) ppm. 13C{1H} NMR (100 MHz, CDCl3): δ = 197.7,
195.1, 152.3, 149.3, 141.0, 140.9, 139.7, 138.8, 137.7, 130.0, 128.1,
127.8, 127.0, 126.1, 123.9, 123.6, 122.2, 121.6, 120.5, 120.4, 120.3,
110.3, 27.0 ppm. HRMS (ESI): calcd for C26H19N2O2 [M + H]+
391.1441; found 391.1442.
(3,6-Dibromo-9-(pyridin-2-yl)-9H-carbazol-1-yl)(4-
methoxyphenyl)methanone (11q).12 Product was purified using
column chromatography on silica gel (eluent: hexane/ethyl acetate
1
95:5 to 90:10); white solid (72% using GP-1), mp 176−178 °C; H
NMR (500 MHz): δ = 8.32 (1H, d, J = 1.6 Hz), 8.23 (1H, d, J = 1.6 Hz),
8.08−8.07 (1H, m), 7.77 (1H, dt, J = 1.5 Hz, 7.6 Hz), 7.61−7.58 (3H,
m), 7.51 (1H, dd, J = 1.7 Hz, 8.6 Hz), 7.33 (2H, dd, J = 1.7 Hz, 8.6 Hz),
7.11 (1H, dd, J = 4.9 Hz, 7.3 Hz), 6.82 (2H, d, J = 8.7 Hz), 3.86 (3H, s);
13C{1H} NMR (100 MHz): δ = 192.9, 163.8, 151.4, 149.5, 139.9,
138.8, 136.8, 132.4, 130.3, 129.9, 126.5, 126.4, 125.4, 124.6, 123.4,
120.7, 120.5, 114.5, 113.7, 113.3, 112.1, 55.7; HRMS (ESI) calcd for
C25H17Br2N2O2[M + H]+: 534.9657; found: 534.9653.
Methyl 4-(3,6-Dibromo-9-(pyridin-2-yl)-9H-carbazole-1-
carbonyl)benzoate (11k).12 Product was purified using column
chromatography on silica gel (eluent: hexane/ethyl acetate 95:5 to
85:15); white solid (74% using GP-1), mp 204−206 °C; 1H NMR (500
MHz): δ = 8.35 (1H, d, J = 2.5 Hz), 8.22 (1H, d, J = 1.6 Hz,), 8.03−7.98
(3H, m), 7.76 (1H, dt, J = 1.7 Hz, 7.9 Hz), 7.65 (2H, d, J = 8.3 Hz), 7.60
(2-Methoxyphenyl)(9-(pyridin-2-yl)-9H-carbazol-1-yl)-
methanone (3m). Product was purified using column chromatography
on silica gel (eluent: hexane/ethyl acetate 95:5 to 80:20); white solid
(67% using GP-1), mp 216−220 °C. 1H NMR (500 MHz, CDCl3): δ =
8.37 (dd, J = 4.9, 1.9 Hz, 1 H), 8.27 (d, J = 7.6 Hz, 1 H), 8.14 (d, J = 7.7
1404
J. Org. Chem. 2021, 86, 1396−1407